Jill L. Schwartz

Tenofovir-Based Preexposure Prophylaxis for HIV Infection among African Women

Jeanne Marrazzo, Gita Ramjee, Barbra A. Richardson et al. · New England Journal of Medicine · 2015 · 1.3K citations · Full text

Public Health, Pharmacotherapy, Preventive Medicine +17

<i>In Vitro</i> and <i>in Vivo</i> Characterization of a Potential Universal Placebo Designed for Use in Vaginal Microbicide Clinical Trials

Deborah Tien, Roger L. Schnaare, Feirong Kang et al. · AIDS Research and Human Retroviruses · 2005 · 177 citations

Public Health, Pharmaceutics, Drug Delivery +14

The Tablets, Ring, Injections as Options (<scp>TRIO</scp>) study: what young African women chose and used for future <scp>HIV</scp> and pregnancy prevention

Ariane van der Straten, Kawango Agot, Khatija Ahmed et al. · Journal of the International AIDS Society · 2018 · 110 citations · Full text

Public Health, Maternal Health, Preventive Medicine +17

A Multi-Compartment, Single and Multiple Dose Pharmacokinetic Study of the Vaginal Candidate Microbicide 1% Tenofovir Gel

Jill L. Schwartz, Wes Rountree, Angela D. M. Kashuba et al. · PLoS ONE · 2011 · 96 citations · Full text

Pharmacy, Clinical Pharmacokinetics, Pharmacokinetics +15

Tenofovir 1% vaginal gel for prevention of HIV-1 infection in women in South Africa (FACTS-001): a phase 3, randomised, double-blind, placebo-controlled trial

Sinéad Delany‐Moretlwe, Carl Lombard, Deborah Baron et al. · The Lancet Infectious Diseases · 2018 · 96 citations

Public Health, Infectious Diseases, Preventive Medicine +17